Showing results (231-240 of 238) with videos related to
Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.The New England Journal of Medicine|May 4, 2022
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 VaccineKaren J Hager, Gonzalo Pérez Marc, Philipe Gobeil, et al.Nature Communications|November 25, 2017
Initiation of HIV neutralizing B cell lineages with sequential envelope immunizationsWilton B Williams, Jinsong Zhang, Chuancang Jiang, et al.The Lancet. Infectious Diseases|January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre studySaranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.The Journal of Infectious Diseases|June 27, 2022
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, One Dintwe, Sheetal Sawant, et al.The New England Journal of Medicine|March 24, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in AdultsGlenda E Gray, Linda-Gail Bekker, Fatima Laher, et al.Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.Science Translational Medicine|July 28, 2021
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.Pageof 24